The Principles of Clinical Cytogenetics - Extra Materials - Springer

Genomic Imprinting and Uniparental Disomy 535
112. Lam, W.W.K., Hatada, I., Ohishi, S., et al. (1999) Analysis of germline CDKN1C (p57 KIP2 ) mutations in familial and
sporadic Beckwith–Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J. Med. Genet. 36,
518–523.
113. Ping, A.J., Reeve, A.E., Law, D.J., Young, M.R., Boehnke, M., and Feinberg, A.P. (1989) Genetic linkage of Beckwith–
Wiedemann syndrome to 11p15. Am. J. Hum. Genet. 44, 720–723.
114. Koufos, A., Grundy, P., Morgan, K., Aet al. (1989) Familial Wiedemann–Beckwith syndrome and a second Wilms
tumor locus both map to 11p15.5. Am. J. Hum. Genet. 44, 711–719.
115. Lee, M.P., DeBaun, M.R., Mitsuya, K., et al. (1999) Loss of imprinting of a paternally expressed transcript, with
antisense orientation to KVLQT1, occurs frequently in Beckwith–Wiedemann syndrome and is independent of insulinlike
growth factor II impringting. Proc. Natl. Acad. Sci. USA 96, 5203–5208.
116. Lee, M., Brandenburg, S., Landes, G., Adams, M., Miller, G., and Feinberg, A. (1999) Two novel genes in the center of
the 11p15 imprinted domain escape genomic imprinting. Hum. Mol. Genet. 8, 683–690.
117. Matsuoka, S., Thompson, J.S., Edwards, M.C., et al. (1996) Imprinting of the gene encoding a human cyclin-dependent
kinase inhibitor, p57 KIP2 , on chromosome 11p15. Proc. Natl. Acad. Sci. USA 93, 3026–3030.
118. Hatada, I., Inazawa, J., Abe, T., et al. (1996) Genomic imprinting of human p57 KIP2 and its reduced expression in
Wilms’ tumors. Hum. Mol. Genet. 5, 783–788.
119. Mitsuya, K., Meguro, M., Le, M.P., et al. (1999) LIT1, an imprinted antisense RNA in the human KvLQT1 locus
identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum. Mol. Genet. 8,
1209–1217.
120. Reik, W., Brown, K.W., Schneid, H., Le Bouc, Y., Bickmore, W., and Maher, E.R. (1995) Imprinting mutations in the
Beckwith–Wiedemann syndrome suggested by altered imprinting pattern in the IGF2–H19 domain. Hum. Mol. Genet.
4, 2379–2385.
121. Gaston, V., Le Bouc, Y., Soupre, V., et al. (2001) Analysis of the methylation status of the KCNQ1OT and H19
genes in leukocyte DNA for the diagnosis and prognosis of Beckwith–Wiedemann syndrome. Eur. J. Hum. Genet. 9,
409–418.
122. Heutink, P., van der Mey, A.G.L., Sandkuijl, L.A., et al. (1992) A gene subject to genomic imprinting and responsible
for hereditary paragangliomas maps to chromosome 11q23-qter. Hum. Mol. Genet. 1, 7–10.
123. Mariman, E.C.M., van Beersum S.E.C., Cremers, C.W.R.J., van Baars, F.M., and Ropers, H.H. (1993) Analysis of a
second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of
chromosome 11q. Hum. Genet. 91, 357–361.
124. Baysal, B.E., Ferrell, R.E., Willett-Brozick, J.E., Lawrence, E.C., et al. (2000) Mutations in SDHD, a mitochondrial
complex II gene, in hereditary paraganglioma. Science 287, 848–851.
125. Milunsky, J.M., Maher, T.A., Michels, V.V., and Milunsky, A. (2001) Novel mutations and the emergence of a common
mutation in the SDHD gene causing familial paraganglioma. Am. J. Med. Genet. 100, 311–314.
126. Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., et al. (2001) The R22X mutation of the SDHD gene in hereditary
paraganglioma abolishes the enzymatic activity of complex II in the mitochonbdrial respiratory chain and activates the
hypoxia pathway. Am. J. Hum. Genet. 69, 1186–1197.
127. van der Mey, A.G., Maaswinkel-Mooy, P.D., Cornelisse, C.J., Schmidt, P.H., and van de Kamp, J.J. (1989) Genomic
imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 2, 1291–1294.
128. van Gils, A.P., van der Mey, A.G., Hoogma, R.P., et al. (1992) MRI screening of kindred at risk of developing paragangliomas:
support for genomic imprinting in hereditary glomus tumours. Br. J. Cancer 65, 903–907.
129. Schroeder, W.T., Chao, L-Y., Dao, D.D., et al. (1987) Nonrandom loss of maternal chromosome 11 alleles in Wilms
tumors. Am. J. Hum. Genet. 40, 413–420.
130. Mannens, M., Slater, R.M., Heyting, C., et al. (1988) Molecular nature of genetic changes resulting in loss of heterozygosity
of chromosome 11 in Wilms’ tumors. Hum. Genet. 81, 41–48.
131. Scrable, H., Cavenee, W., Ghavimi, F., Lovell, M., Morgan, K., and Sapienza, C. (1989) A model for embryonal
rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl. Acad. Sci. USA 86, 7480–7484.
132. Koi, M., Johnson, L.A., Kalikin, L.M., Little, P.F., Nakamura, Y., and Feinberg, A.P. (1993) Tumor cell growth arrest
caused by subchromosomal transferable DNA fragments from chromosome 11. Science 260, 361–364.
133. Ogawa, O., Eccles, M.R., Szeto, J., et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated
in Wilms’ tumour. Nature 362, 749–751.
134. Wu, H.K., Squire, J.A., Catzavelos, C.G., and Weksberg, R. (1997) Relaxation of imprinting of human insulin-like
growth factor II gene, IGF2, in sporadic breast carcinomas. Biochem. Biophys. Res. Commun. 235, 123–129.
135. Wang, W.H., Duan, J.X., Vu, T.H., and Hoffman, A.R. (1996) Increased expression of the insulin-like growth factor-II
gene in Wilms’ tumor is not dependent on loss of genomic imprinting or loss of heterozygosity. J. Biol. Chem. 271,
27,863–27,870.
136. Friend, S.H., Bernards, R., Rogelj, S., et al. (1986) A human DNA segment with properties of the gene that predisposes
to retinoblastoma and osteosarcoma. Nature 323, 643–646.
137. Ejima, Y., Sasaki, M.S., Kaneko, A., and Tanooka, H. (1988) Types, rates, origin and expressivity of chromosome
mutations involving 13q14 in retinoblastoma patients. Hum. Genet. 79, 118–123.